Cancer‐related mRNA expression analysis using a novel flow cytometry‐based assay. Issue 4 (2nd November 2017)

• Record Type: Journal Article
• Authors: Depreter, Barbara; Philippé, Jan; Meul, Magali; Denys, Barbara; Vandepoele, Karl; De Moerloose, Barbara; Lammens, Tim
• Is Part Of: Cytometry. Volume 94:Issue 4(2018)
• Page Start: 565
• Page End: 575
• Publication Date: 2017-11-02
• Subjects: single‐cell -- heterogeneity -- acute myeloid leukemia -- neuroblastoma -- mRNA; Flow cytometry -- Diagnostic use -- Periodicals; Cytodiagnosis -- Periodicals; 616.07582
• DOI: 10.1002/cyto.b.21593
• Languages: English
• ISSNs: 1552-4949

Abstract

Abstract : Background: Cancer‐related gene expression data mostly originate from unfractionated bulk samples, leading to "expression averaging" of heterogeneous populations. Multicolor flow cytometry (FCM) may distinguish heterogeneous populations based on the phenotypic characterization of single‐cells, but is not applicable for RNA targets. Here, we evaluated the PrimeFlow™ RNA assay, a novel FCM‐based assay designed to measure gene expressions, in two cancer entities with high and low RNA target levels. Methods: Neuroblastoma (NB) cell lines were studied for MYCN gene expression by PrimeFlow™ and compared with the gold standard, RT‐qPCR. Dilution series of NB cells (0.10–11%) were prepared to evaluate performance in small cell populations. Diagnostic material of de novo acute myeloid leukemia (AML) patients was used to measure Wilms' tumor 1 ( WT1 ) expression in bulk leukemic cells and rare subsets, e.g. leukemic stem cells (LSCs). FCM analysis was performed on a FACSCanto II (BD Biosciences) using Infinicyt™ (Cytognos ® ) for data analysis. mRNA expression was reported by normalized mean fluorescence intensity (MFI) values and staining indices. Results: MYCN mRNA quantified by PrimeFlow™ significantly correlated with RT‐qPCR and remained detectable in small (0.1%) populations. Using PrimeFlow TM, WT1 levels were shown to be significantly higher in AML patient samples with WT1 overexpression, previously defined by RT‐qPCR. Moreover, WT1 overexpression was distinguishable between heterogeneous cell populations and remained measurable in rare LSCs. Conclusion: PrimeFlow™ is a sensitive technique to investigate mRNA expressions, with high concordance to RT‐qPCR. High ( MYCN ) and subtle ( WT1 ) overexpressed mRNA targets can be quantified in heterogeneous and rare subpopulations e.g. LSCs. © 2017 International Clinical Cytometry Society